Clarisse, Dorien http://orcid.org/0000-0002-2580-2291
Prekovic, Stefan http://orcid.org/0000-0002-7051-9321
Vlummens, Philip http://orcid.org/0000-0001-8275-2887
Staessens, Eleni http://orcid.org/0000-0001-6810-5069
Van Wesemael, Karlien
Thommis, Jonathan http://orcid.org/0000-0001-7221-9317
Fijalkowska, Daria http://orcid.org/0000-0002-2084-146X
Acke, Guillaume http://orcid.org/0000-0001-6613-5707
Zwart, Wilbert http://orcid.org/0000-0002-9823-7289
Beck, Ilse M. http://orcid.org/0000-0002-1927-5480
Offner, Fritz http://orcid.org/0000-0003-4690-3603
De Bosscher, Karolien http://orcid.org/0000-0001-5059-9718
Funding for this research was provided by:
Agentschap Innoveren en Ondernemen (131374)
Kom op tegen Kanker (KDB 2012-VLK-GC-MM, STI.VLK.2018.0019.01)
Vlaams Instituut voor Biotechnologie (Institutional funding)
Universiteit Gent (Institutional funding)
Article History
Received: 22 May 2023
Revised: 11 July 2023
Accepted: 27 July 2023
First Online: 14 August 2023
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: Informed consent was obtained from all patients included in the study.